BRPI0509878A - ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronária - Google Patents

ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronária

Info

Publication number
BRPI0509878A
BRPI0509878A BRPI0509878-5A BRPI0509878A BRPI0509878A BR PI0509878 A BRPI0509878 A BR PI0509878A BR PI0509878 A BRPI0509878 A BR PI0509878A BR PI0509878 A BRPI0509878 A BR PI0509878A
Authority
BR
Brazil
Prior art keywords
depression
patients
prevention
treatment
heart disease
Prior art date
Application number
BRPI0509878-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Cees-Nico Verboom
Rainer Oelze
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of BRPI0509878A publication Critical patent/BRPI0509878A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0509878-5A 2004-04-16 2005-04-15 ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronária BRPI0509878A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04101578 2004-04-16
PCT/EP2005/004031 WO2005110393A1 (fr) 2004-04-16 2005-04-15 Acides gras essentiels utilises dans la prevention ou le traitement de la depression chez des patients souffrant d'une maladie cardiaque coronarienne ou d'une coronaropathie

Publications (1)

Publication Number Publication Date
BRPI0509878A true BRPI0509878A (pt) 2007-10-16

Family

ID=34928968

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509878-5A BRPI0509878A (pt) 2004-04-16 2005-04-15 ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronária

Country Status (12)

Country Link
EP (1) EP1765319A1 (fr)
JP (1) JP2007532605A (fr)
CN (1) CN1942180A (fr)
AU (1) AU2005244483B2 (fr)
BR (1) BRPI0509878A (fr)
CA (1) CA2504280A1 (fr)
IL (1) IL178300A0 (fr)
MX (1) MX291518B (fr)
RU (1) RU2387448C2 (fr)
UA (1) UA94693C2 (fr)
WO (1) WO2005110393A1 (fr)
ZA (1) ZA200607794B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2421909A (en) * 2004-12-23 2006-07-12 Laxdale Ltd Pharmaceutical compositions comprising EPA and methods of use
ITMI20100961A1 (it) * 2010-05-27 2011-11-28 Erredue Spa Miscele ricche in esteri di acidi grassi omega-3, loro composizioni e loro processo di preparazione

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998048788A1 (fr) * 1997-04-29 1998-11-05 Scotia Holdings Plc Traitement de la depression et de l'anxiete au moyen d'acide docosahexaenoique ou d'antioxydants naturels
BR0209749A (pt) * 2001-05-30 2004-07-27 Laxdale Ltd Coenzima q e epa ou outro ácido graxo essencial

Also Published As

Publication number Publication date
CN1942180A (zh) 2007-04-04
AU2005244483A1 (en) 2005-11-24
AU2005244483B2 (en) 2011-06-09
MXPA06011940A (es) 2006-12-15
WO2005110393A1 (fr) 2005-11-24
ZA200607794B (en) 2008-05-28
CA2504280A1 (fr) 2005-10-16
RU2006140277A (ru) 2008-05-27
UA94693C2 (ru) 2011-06-10
RU2387448C2 (ru) 2010-04-27
MX291518B (es) 2011-10-31
IL178300A0 (en) 2007-02-11
JP2007532605A (ja) 2007-11-15
EP1765319A1 (fr) 2007-03-28

Similar Documents

Publication Publication Date Title
Shahidi et al. Omega-3 polyunsaturated fatty acids and their health benefits
HUP0303019A2 (hu) Esszenciális N-3 zsírsavakat tartalmazó gyógyszerkészítmények alkalmazása a szívgyengeség és szívelégtelenség terápiájában
Singer et al. Slow desaturation and elongation of linoleic and α-linolenic acids as a rationale of eicosapentaenoic acid-rich diet to lower blood pressure and serum lipids in normal, hypertensive and hyperlipemic subjects
Wiktorowska-Owczarek et al. PUFAs: structures, metabolism and functions
BRPI0408006A (pt) uso de ácidos graxos Èmega -3 no tratamento de pacientes diabéticos
US20080113046A1 (en) Use of Omega-3 Fatty Acid(s) for Treating Hypercholesterolemia Caused by Anti-Retroviral Treatment of Hiv-Infected Patients
DE60000133C5 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
WO2008018043A3 (fr) Procédé permettant d'améliorer la santé des os et la santé musculaire
TR201908522T4 (tr) Kan lipidi düşürücü maddeler olarak keton gövdeleri ve keton gövde esterleri.
WO2009091538A3 (fr) Composition pharmaceutique et méthode permettant de traiter l'hypertriglycéridemie et l'hypercholestérolémie chez des mammifères
CO6470839A2 (es) Composiciones farmacéuticas que contienen epa y un agente cardiovascular y métodos de emplearlas
WO2007103160A3 (fr) Moyens d'amélioration de la santé cardio-vasculaire
JPS60115522A (ja) 血中のコレステロ−ル及びトリグリセリドのレベルを低下させるための複合脂肪酸組成物
Shahidi Omega-3 fatty acids and marine oils in cardiovascular and general health: A critical overview of controversies and realities
MA30584B1 (fr) Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires
WO2007070611A3 (fr) Additif nutritionnel contenant des acides gras polyinsatures a longue chaine
NZ627238A (en) Stable pharmaceutical composition comprising ethyl eicosapentaenoate
JP2008525392A (ja) Ｅｐａによる重度のメランコリー型うつ病の治療
NO20076382L (no) Anvendelse av dokosaheksaenglyserider i behandlingen av tumorese sykdommer
JP2008050367A5 (fr)
RU2008103281A (ru) Способы и композиции для профилактики и лечения воспалительного заболевания
Kaur et al. Synthesis and functional significance of poly unsaturated fatty acids (PUFA’s) in body
Harrison et al. The mechanism of action of omega-3 fatty acids in secondary prevention post-myocardial infarction
BRPI0509878A (pt) ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronária
US20100239660A1 (en) Product and use of omega-3s matching human tissue ratios for treatment of inflammatory and other conditions

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: ABBOTT PRODUCTS GMBH (DE)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015.